The role of radiosurgery in the management of malignant brain tumors

Current Treatment Options in Oncology

Volumn 6, Issue 6, 2005, Pages 501-508

  Stieber, Volker W ^a   Ellis, Thomas L ^b  

^a WAKE FOREST BAPTIST HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; STEROID; TEMOZOLOMIDE;

ACCURACY; BRAIN CANCER; BRAIN EDEMA; BRAIN METASTASIS; BRAIN NECROSIS; BRAIN SURGERY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; GAMMA KNIFE; GLIOBLASTOMA; HUMAN; IONIZING RADIATION; LINEAR ACCELERATOR; PALLIATIVE THERAPY; PATIENT POSITIONING; PROGNOSIS; PROTON RADIATION; QUALITY OF LIFE; RADIATION BEAM; RADIATION DOSE; RADIOBIOLOGY; RADIOSURGERY; RECURRENT DISEASE; REVIEW; SALVAGE THERAPY; STEREOTAXIC SURGERY; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TUMOR VOLUME;

BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; GLIOMA; HUMANS; RADIOSURGERY; SALVAGE THERAPY;

EID: 29844442014     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-005-0028-8     Document Type: Review

References (46)

1. Leksell L: Stereotactic radiosurgery. J Neurol Neurosurg Psychiatry 1983, 46:797-803.
2. Brahme A: Individualizing cancer treatment: biological optimization models in treatment planning and delivery. Int J Radiat Oncol Biol Phys 2001, 49:327-337.
3. Leksell Gamma Knife Society: Treatment statistics. http://www.elekta.com. Accessed June 18, 2005.
4. Andrews DW, Scott CB, Sperduto PW, et al.: Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363:1665-1672.
5. Flickinger JC, Kondziolka D, Niranjan A, et al.: Results of acoustic neuroma radiosurgery: an analysis of 5 years' experience using current methods. J Neurosurg 2001, 94:1-6.
6. Flickinger JC, Maesawa S, Kondziolka D, et al.: An analysis of the clinical radiobiology of arteriovenous malformation obliteration by radiosurgery. Int J Radiat Oncol Biol Phys 2000, 48:255.
7. Izawa M, Hayashi M, Nakaya K, et al.: Gamma knife radiosurgery for pituitary adenomas. J Neurosurg 2000, 93(Suppl 3):19-22.
8. Stafford SL, Pollock BE, Foote RL, et al.: Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery 2001, 49:1029-1037.
9. Pollock BE, Phuong LK, Gorman DA, et al.: Stereotactic radiosurgery for idiopathic trigeminal neuralgia. J Neurosurg 2002, 97:347-353.
10. Young RF, Shumway-Cook A, Vermeulen SS, et al.: Gamma knife radiosurgery as a lesioning technique in movement disorder surgery. J Neurosurg 1998, 89:183-193.
11. International Agency for Research on Cancer: World Health Organization Classification of Tumours: Pathology and Genetics: Tumours of the Nervous System, edn 2. Edited by Kleihues P, Cavenee WK. Lyon, France: Oxford University Press; 2000.
12. CBTRUS: Statistical report: primary brain tumors in the United States, 1997-2001 years data collected. Chicago, IL: Central Brain Tumor Registry United States; 2004.
13. Ferlay J, Bray F, Pisani P, et al.: GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide, version 1.0. IARC CancerBase No. 5. Lyon, France: IARC Press; 2001.
14. American Cancer Society: Cancer Facts and Figures 2005. Atlanta, GA: American Cancer Society; 2005.
15. Scott CB, Scarantino C, Urtasun R, et al.: Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radiat Oncol Biol Phys 1998, 40:51-55.
16. Curran WJ Jr, Scott CB, Horton J, et al.: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993, 85:704-710.
17. Shaw EG, Seiferheld W, Scott C, et al.: Reexamining the radiation therapy oncology group (RTOG) recursive partitioning analysis (RPA) for glioblastoma multiforme (GBM) patients. Int J Radiat Oncol Biol Phys 2003, 57:S135-S136.
18. Walker MD, Alexander E Jr, Hunt WE, et al.: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 1978, 49:333-343.
19. Stupp R, Mason WP, van den Bent MJ, et al.: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352:987-996.
20. Lacroix M, Abi-Said D, Fourney DR, et al.: A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001, 95:190-198.
21. Walker MD, Strike TA, Sheline GE: An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 1979, 5:1725-1731.
22. Lee SW, Fraass BA, Marsh LH, et al.: Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study. Int J Radiat Oncol Biol Phys 1999, 43:79-88.
23. Selker RG, Shapiro WR, Burger P, et al.: The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurgery 2002, 51:343-355.
24. Souhami L, Seiferheld W, Brachman D, et al.: Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 2004, 60:853-860.
25. Buatti JM, Friedman WA, Bova FJ, et al.: Linac radiosurgery for high-grade gliomas: the University of Florida experience. Int J Radiat Oncol Biol Phys 1995, 32:205-210.
26. Kondziolka D, Flickinger JC, Bissonette DJ, et al.: Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 1997, 41:776-783.
27. Sarkaria JN, Mehra MP, Loeffler JS, et al.: Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Int J Radiat Oncol Biol Phys 1995, 32:931-941.
28. Shaw E, Scott C, Souhami L, et al.: Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000, 47:291-298.
29. Tatter SB: Recurrent malignant glioma in adults. Curr Treat Options Oncol 2002, 3:509-524.
30. Percy AK, Elveback LR, Okazaki H, et al.: Neoplasms of the central nervous system. Epidemiologic considerations. Neurology 1972, 22:40-48.
31. Walker AE, Robins M, Weinfeld FD: Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 1985, 35:219-226.
32. Barnholtz-Sloan JS, Sloan AE, Davis FG, et al.: Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 2004, 22:2865-2872.
33. Schouten LJ, Rutten J, Huveneers HA, et al.: Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002, 94:2698-2705.
34. Hazuka MB, Burleson WD, Stroud DN, et al.: Multiple brain metastases are associated with poor survival in patients treated with surgery and radiotherapy. J Clin Oncol 1993, 11:369-373.
35. Patchell RA: The management of brain metastases. Cancer Treat Rev 2003, 29:533-540.
36. Patchell RA, Tibbs PA, Walsh JW, et al.: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990, 322:494-500.
37. Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al.: Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993, 33:583-590.
38. Mintz AH, Kestle J, Rathbone MP, et al.: A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996, 78:1470-1476.
39. Gaspar L, Scott C, Rotman M, et al.: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37:745-751.
40. Gaspar LE, Scott C, Murray K, et al.: Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 2000, 47:1001-1006.
41. Nieder C, Andratschke N, Grosu AL, et al.: Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases. Strahlenther Onkol 2003, 179:16-20.
42. Sanghavi SN, Miranpuri SS, Chappell R, et al.: Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 2001, 51:426-434.
43. Kondziolka D, Patel A, Lunsford LD, et al.: Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999, 45:427-434.
44. Patchell RA, Tibbs PA, Regine WF, et al.: Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998, 280:1485-1489.
45. Aoyama H, Shirato H, Nakagawa K, et al.: Interim report of the JROSG99-1 multi-institutional randomized trial, comparing radiosurgery alone vs. radiosurgery plus whole brain irradiation for 1-4 brain metastases [abstract]. J Clin Oncol 2005, In press.
46. American College of Surgeons Oncology Group: Z0300: A phase III randomized trial of the role of whole brain radiation therapy in addition to radiosurgery in the management of patients with one to three cerebral metastases. https://www.acosog.org/studies/synopses/Z0300_synopsis.pdf Accessed July 4, 2005.